Glow (BPC-157 + TB-500 + GHK-Cu)
Glow (BPC-157 + TB-500 + GHK-Cu) is supplied by White Label Peptides as a lyophilised powder in multi-dose vials, for laboratory and research use, to business buyers only. It sits in our beauty category. Every batch is verified by HPLC and ships with its own Certificate of Analysis.
| Purity | ≥98% (HPLC-verified, batch-by-batch - all three compounds) |
|---|---|
| Form | Lyophilised powder (vials) or ready-to-use solution (pre-filled pens) |
| Appearance | White to off-white to pale blue lyophilised powder prior to reconstitution (GHK-Cu contributes a blue tint due to its copper-binding properties) |
| Presentation | Vials: 10+10+50 mg. Pre-filled pens: 10+10+50 mg |
| Reconstitution | Reconstitute using bacteriostatic water or sterile laboratory-grade water |
| Storage | Store refrigerated at 2-8°C in a cool, dry environment away from direct light. For long-term storage prior to reconstitution, freezing conditions are recommended. Storage conditions are confirmed on the Certificate of Analysis supplied with each order. |
| Bpc157 Cas Number | 137525-51-0 |
| Bpc157 Molecular Formula | C62H98N16O22 |
| Bpc157 Molecular Weight | Approximately 1419.5 g/mol |
| Bpc157 Sequence | GEPPPGKPADDAGLV |
| Ghkcu Cas Number | 49557-75-7 |
| Ghkcu Molecular Formula | C14H24CuN6O4 |
| Ghkcu Molecular Weight | Approximately 340.9 g/mol |
| Ghkcu Sequence | Glycine - Histidine - Lysine bound to Copper (Cu²⁺) |
| Tb500 Cas Number | 77591-33-4 |
| Tb500 Molecular Formula | C212H350N56O78S |
| Tb500 Molecular Weight | Approximately 4963 g/mol |
| Tb500 Structure | Synthetic peptide version of the active region of Thymosin Beta-4, involved in cellular migration and tissue-related research processes |
Specification data is provided for identification and procurement. It is not dosing guidance and it is not a claim of any effect.
Evidence and status
- Lab work
- Animal studies
- Human studies
- Approved label
Reviewed 2026-09-02. Regulatory status is stated for procurement and varies by market. It is not legal advice.
Research
What the published literature examined
Nothing has examined this combination. Each constituent has its own separate literature, set out in full on its own page: BPC-157 reaches human studies, TB-500 reaches animal studies, and GHK-Cu reaches animal studies with an ongoing phase 2 study of a topical gel. Those three bodies of work share no study, no species and no route. No pharmacokinetic work describes any of the three in the presence of the others, and the copper complex in particular has been characterised topically rather than by the route this presentation implies.
What is not established
Everything specific to the combination, and one thing more. Beyond the absent interaction, pharmacokinetic, safety and dose-finding data that any unstudied blend lacks, the GHK-Cu evidence base is topical while this is a vial. The strongest published work on that constituent describes a route this product does not use, which is a weaker position than the constituent page alone would suggest.
What distinguishes Glow (BPC-157 + TB-500 + GHK-Cu)
Three separately documented materials in one vial, and nothing published on the three together. Each constituent has its own page here with its own evidence ladder and its own sources, so the blend can be assessed by reading three real evidence bases rather than one invented one. It is also the only product in the catalogue where a constituent's strongest evidence sits on a different route from the presentation, and that is stated here rather than left for a buyer to notice.
Sources
- US FDA. Briefing document, Pharmacy Compounding Advisory Committee, evaluation of BPC-157-related bulk drug substances, 11 May 2026
- US FDA. Briefing document, Pharmacy Compounding Advisory Committee: evaluation of TB-500-related bulk drug substances, 15 May 2026
- US FDA. Certain bulk drug substances for use in compounding that may present significant safety risks, GHK-Cu entry, injectable routes
- ClinicalTrials.gov. NCT07437586, phase 2 randomised study of a topical GHK-Cu gel against vehicle
- World Anti-Doping Agency. 2026 Prohibited List, sections S0 and S2.3
This page describes a compound as a material and summarises published research about it. It is for general and procurement information only. It is not medical advice, not a treatment recommendation, and not guidance on use. Supplied for laboratory and research use, not for human consumption.
Specification
About this compound
The specification below is the batch-independent data. Purity and analysis date vary by batch, so they appear on the certificate issued with your order rather than on this page.
What this compound is
Glow (BPC-157 + TB-500 + GHK-Cu) in supply terms
Glow is a pre-blended vial combining three separate peptides rather than a single compound: BPC-157 at 10mg, TB-500 at 10mg, and GHK-Cu at 50mg, for a combined fill weight of 70mg per vial. Each component keeps its own chemical identity within the vial; blending does not create a new molecular species, and each compound carries its own CAS number, formula and molecular weight. BPC-157 (CAS 137525-51-0) is a 15-residue synthetic peptide with the sequence GEPPPGKPADDAGLV, formula C62H98N16O22, molecular weight near 1419.5 g/mol. TB-500 (CAS 77591-33-4) corresponds to a specific active region of the Thymosin Beta-4 protein, reproduced synthetically, with formula C212H350N56O78S and a molecular weight near 4963 g/mol, the largest single component by mass in this blend. GHK-Cu (CAS 49557-75-7) is the copper-coordinated tripeptide described elsewhere on this catalogue, formula C14H24CuN6O4, molecular weight near 340.9 g/mol, and it is what gives the powder its pale blue tint against the white to off-white color of the other two components. The blend is lyophilised as a single powder in multi-dose vials, all three components verified to at least 98 percent purity by HPLC, and reconstitutes with bacteriostatic water or sterile laboratory-grade water. Store at 2-8C away from direct light, with freezing recommended for extended storage. Buyers should compare the per-vial total against sourcing the three compounds separately, since blend pricing and single-compound pricing do not always scale the same way per milligram.
This section describes the compound as a material. It makes no claim about any effect and is not guidance on use.
What varies by batch
The page identifies the compound. The certificate records the batch.
Purity, method, analysis date and issuing party belong on the batch record rather than in page copy.
| Send the volume you need for Glow (BPC-157 + TB-500 + GHK-Cu) and your delivery country. We will quote against it. | Request pricing |
Same category
Also in Beauty
| Compound | Identifier | Presentation |
|---|---|---|
| GHK-Cu | C14H24N6O4Cu | Vials: 50 mg, 100 mg. Pre-fille... |
| Glutathione | 70-18-8 | Vials: 1500 mg. Pre-filled pens... |
| Melanotan II (MT-2) | 121062-08-6 | Vials: 10 mg. Pre-filled pens: ... |
Questions
Supply, answered
Is Glow (BPC-157 + TB-500 + GHK-Cu) available for private label?
Yes. It can be supplied under your own brand on the vial and the carton, with the Certificate of Analysis issued under your product name.
What is the minimum order quantity?
Set for this compound specifically and confirmed at the enquiry stage, before you commit.
What purity is supplied?
98 percent or higher, verified by HPLC. The certificate issued with your batch carries the actual figure for that batch.
How is it shipped?
As lyophilised powder in multi-dose vials, packed for transit. Delivery in 5 to 7 days once the batch is released.
We already buy Glow (BPC-157 + TB-500 + GHK-Cu). Can you quote against our current volume?
Yes. Send the volume and the delivery country. Pricing is tiered per compound, so the quote reflects what you buy rather than a list price.
Can you supply Glow (BPC-157 + TB-500 + GHK-Cu) as a second source?
Yes. Terms are agreed per compound, so you can add Glow (BPC-157 + TB-500 + GHK-Cu) without moving anything else you buy elsewhere.
Request pricing for Glow (BPC-157 + TB-500 + GHK-Cu)
Indicative volume and delivery country is enough to start. We reply within one working day.